P911: EVALUATION OF PROPHYLACTIC TOCILIZUMAB (TOCI) FOR THE REDUCTION OF CYTOKINE RELEASE SYNDROME (CRS) TO INFORM THE MANAGEMENT OF PATIENTS (PTS) TREATED WITH TECLISTAMAB IN MAJE...

por van de Donk, Niels W.C.J., Garfall, Alfred, Benboubker, Lotfi, Uttervall, Katarina, Groen, Kaz, Rosiñol Dachs, Laura, Hodin, Caroline, Stephenson, Tara, Trancucci, Danielle, Perales-Puchalt, Alfredo, Kobos, Rachel, Banerjee, Arnob, Mateos, Maria-Victoria
Publicado 2023

FXR agonism protects against liver injury in a rat model of intestinal failure-associated liver disease

por Koelfat, Kiran V.K., Visschers, Ruben G.J., Hodin, Caroline M.J.M., de Waart, D. Rudi, van Gemert, Wim G., Cleutjens, Jack P.M., Gijbels, Marion J., Shiri-Sverdlov, Ronit, Mookerjee, Rajeshwar P., Lenaerts, Kaatje, Schaap, Frank G., Steven W.M., Olde Damink
Publicado 2017